Leveraging solid multi-jurisdictional capabilities, Bristows LLP is highly regarded for its handling of cross-border funding rounds and equity investments. Operating out of London, practice head Iain Redford is well versed in the TMT and life sciences spheres, Marek Petecki regularly advises on venture capital transactions, and David Horner concentrates on equity financing issues. Nick Cross is knowledgeable in general corporate affairs, and both Samuel Munday and Molly Whitehall are also noted.
Legal 500 Editorial commentary
Key clients
- Diageo
- Syncona
- Johnson & Johnson Innovations
- IP Group plc
- Oxford Science Enterprises plc
- Braavos Capital
- Cambridge Innovation Capital
- Francis Crick Institute
- UCL Business
- LifeArc
- Kaluza
- Mosaic Therapeutics
Work highlights
Advised Beacon Therapeutics on its raising of $170m in Series B Funding to advance the development of ophthalmic gene therapies.
Advised Oxford Science Enterprises on its participation in Amber Therapeutics’ $100m Series A Financing.
Advised energy software platform Kaluza on its $100m equity investment by AGL, a publicly-listed Australian energy company.
Practice head
Iain Redford
Other key lawyers
Marek Petecki; David Horner; Nick Cross; Samuel Munday; Molly Whitehall